Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT05381584
Other study ID # vagioplasty in vaginal aplasia
Secondary ID
Status Not yet recruiting
Phase N/A
First received
Last updated
Start date July 2022
Est. completion date October 2023

Study information

Verified date May 2022
Source Assiut University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Vaginal aplasia is a congenital anomaly characterized by congenital absence of the vagina with an incidence approximately 1:4,500-6,000. It carries an emotional, sexual, and social embarrassing effect on those women, The primary aim of treatment is creation of a neo vagina for restoration of the ability for vaginal intercourse. There are several techniques for neo vaginal construction with variable satisfaction rates. Most of these procedures are either invasive and technically demanding or require long duration in a very motivated patient


Description:

Numerous surgical and nonsurgical procedures with varying degrees of success have been described for correction of the vaginal aplasia, but none have proved to be universally accepted. Balloon vaginoplasty was first introduced in 2003 by El Saman et al for construction of a naturally lined neo vagina through a laparoscopic. Technique hosts the triad of a perfect management modality; namely: simplicity, safety and success. The technique acts via mechanical expansion of the vaginal epithelium and underlying tissues at the pre-existing vaginal dimple Being a relatively new modality of management, it went through many refinements to make it much easier and feasible. The cornerstone of refinement always ran around the access to the peritoneal cavity. The latest of which was the fractionated intra umbilical micro ports which have the merits of totally hidden scar at the bottom the umbilicus consequently the best cosmetic outcomes. However, during its insertion process a troublesome partially unmonitored insertion was inevitably observed


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 60
Est. completion date October 2023
Est. primary completion date September 2023
Accepts healthy volunteers No
Gender Female
Age group N/A and older
Eligibility Inclusion Criteria: - Married Females with vaginal aplasia scheduled for balloon vaginoplasty. Exclusion Criteria: - Females who refused to consent for participation in the study. - Unstable marital relationship.

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
laparoscopy
laparoscopy will be done under anesthesia for management for cases with blind vagina

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Assiut University

Outcome

Type Measure Description Time frame Safety issue
Primary The Operative time duration of surgery will be calculated from start of laparoscopy 1 hour
See also
  Status Clinical Trial Phase
Terminated NCT03185169 - GSM (Genitourinary Syndrome Of Menopause) Management In Breast Cancer Survivors Early Phase 1
Recruiting NCT05165056 - Photobiomodulation Therapy in the Prevention and Management of Radiotherapy-induced Vaginal Toxicity N/A
Suspended NCT03547089 - A Prospective Trial to Assess Breast Cancer Survivors and Vaginal Atrophy Treatment Outcomes N/A
Recruiting NCT06311812 - Retrospective Review on Uterovaginal Anomalies